Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Mellitus Poor Control”

66 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 66 results

Post-approval studies (Phase 4)Looking for participantsNCT07244003
What this trial is testing

Efficacy and Safety of the Met+SGLT-2i+GLP-1RA in Patients With Type 2 Diabetes With Poor Glycemic Control

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 430
Not applicableActive Not RecruitingNCT07469995
What this trial is testing

The Effect of Grocery Support Dose on Food Insecurity and Disease Control Among Covered California Members With Diabetes or Hypertension

Who this might be right for
DiabetesHypertensionFood Insecurity+2 more
University of California, San Francisco 4,450
Testing effectiveness (Phase 2)UnknownNCT02917928
What this trial is testing

The Potential of Carnosine Supplementation in Optimising Cardiometabolic Health

Who this might be right for
Poor Glycemic ControlCardiovascular Risk FactorsCognitive Function 1, Social
Monash University 40
Not applicableWithdrawnNCT05765903
What this trial is testing

UM CRMC RecuR Score Pilot

Who this might be right for
Patient ReadmissionPulmonary Disease, Chronic ObstructiveHeart Failure+3 more
University of Maryland, Baltimore
Not applicableStudy completedNCT00441129
What this trial is testing

Obtain a Good Blood Glucose Control With the Paradigm Real Time System

Who this might be right for
Type 1 Diabetes
Medtronic MiniMed, Inc. 115
Not applicableLooking for participantsNCT06658067
What this trial is testing

Continuous Glucose Monitors (CGMs) for All: Studying the Impact of Expanding CGM Access

Who this might be right for
DiabetesType 2 DiabetesType 2 Diabetes Mellitus - Poor Control
Yale University 17
Not applicableStudy completedNCT07529184
What this trial is testing

Evaluation of the Impact of a Food is Medicine Program on Diabetes-related Health Outcomes for People With Type 2 Diabetes in a Low Income Community-based Setting Compared to Usual Care

Who this might be right for
Diabetes (DM)
Public Health Institute Center for Wellness and Nutrition 405
Not applicableStudy completedNCT02530450
What this trial is testing

Continuous Glucose Monitor in Children With Poorly Controlled Diabetes

Who this might be right for
Type 1 Diabetes Mellitus
The University of Texas Health Science Center at San Antonio 30
Not applicableUnknownNCT06007014
What this trial is testing

Efficacy and Safety of Chiglitazar Added to Glargine in Patients With Type 2 Diabetes

Who this might be right for
Efficacy and Safety of Chiglitazar Sodium in the Treatment of T2DM PatientsMetformin Combined With Insulin Glargine in the Treatment of Type 2 Diabetes Patients Who Still Have Poor Hypoglycemic Effect128 Patients Were Randomly Assigned 1:1+4 more
Yanbing Li 128
Large-scale testing (Phase 3)Active Not RecruitingNCT06649773
What this trial is testing

The Experiment of Noiiglutide Injection in Type 2 Diabetes Patients

Who this might be right for
Type 2 Diabetes
Jiangsu HengRui Medicine Co., Ltd. 137
Not applicableLooking for participantsNCT05899023
What this trial is testing

ED Diabetes Screening and Outpatient Care - Aim 3

Who this might be right for
Diabetes MellitusNon Insulin Dependent Diabetes Mellitus
NYU Langone Health 200
Testing effectiveness (Phase 2)UnknownNCT01324557
What this trial is testing

Insulin Pump Therapy and Continuous Glucose Monitoring in Diabetic Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients

Who this might be right for
DiabetesPoor Glycemic Control
Guangdong Provincial People's Hospital 44
Not applicableStudy completedNCT00519935
What this trial is testing

Testing MST to Improve Adherence Among Youth With Chronic Poor Metabolic Control

Who this might be right for
Type 1 Diabetes
Wayne State University 127
Not applicableUnknownNCT04932356
What this trial is testing

Telephone Therapeutic Education Program in DM2 Patients With Poor Metabolic Control

Who this might be right for
Diabetes Mellitus, Type 2
Mª Dolores Rodríguez Garrido 76
Large-scale testing (Phase 3)UnknownNCT05318326
What this trial is testing

A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial to Evaluate the Clinical Efficacy and Safety of Yogliptin Tablets

Who this might be right for
Type 2 Diabetes
Chengdu Easton Biopharmaceuticals Co,Ltd 450
Not applicableStudy completedNCT03480945
What this trial is testing

Glycemic Control and Endothelial Function in Patients With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Karolinska Institutet 16
Large-scale testing (Phase 3)Study completedNCT06350890
What this trial is testing

Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes

Who this might be right for
T2DM (Type 2 Diabetes Mellitus)
HighTide Biopharma Pty Ltd 408
Not applicableStudy completedNCT02456064
What this trial is testing

Impact of a Program of Non-pharmacological Intervention in Patients With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Type 2
Equipo Multidisciplinar Sanitario CS Foietes 25
Not applicableStudy completedNCT03549845
What this trial is testing

Cardiovascular Health Awareness Program (CHAP) in Subsidized Social Housing

Who this might be right for
Cardiovascular DiseasesCardiovascular Risk FactorDiabetes Mellitus
McMaster University 2,742
Large-scale testing (Phase 3)Study completedNCT00468039
What this trial is testing

A Sub-study to LMF237A2302 to Assess the Effect of 24 Weeks Treatment With Initial Combination of Vildagliptin Plus Metformin

Who this might be right for
Diabetes Mellitus, Type 2
Novartis 94
Load More Results